24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Preventing GlaucomaHead Injuries Tied to Motorized Scooters Are Rising: StudyOverweight Kids Are at Risk for High Blood PressureHot Water Soak May Help Ease Poor Leg CirculationHealth Tip: Understanding RosaceaHealth Tip: Causes of Swollen Lymph NodesAHA News: Study Provides Rare Look at Stroke Risk, Survival Among American IndiansCDC Opens Emergency Operations Center for Congo Ebola OutbreakScared Safe: Pics of Sun's Damage to Face Boost Sunscreen UseNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodBats Are Biggest Rabies Danger, CDC SaysEmgality Receives First FDA Approval for Treating Cluster HeadacheZerbaxa Approved for Hospital-Acquired Bacterial PneumoniaBlood From Previously Pregnant Women Is Safe for Donation: StudyStudy Refutes Notion That People on Warfarin Shouldn't Eat Leafy GreensCancer Survivors Predicted to Top 22 Million by 2030Your Guide to a Healthier Home for Better Asthma ControlHigh Blood Pressure at Doctor's Office May Be More Dangerous Than SuspectedAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideHealth Tip: Dealing With Motion SicknessHealth Tip: Symptoms of MeningitisRace Affects Life Expectancy in Major U.S. CitiesVitamin D Supplements Don't Prevent Type 2 Diabetes: StudyChickenpox Vaccine Shields Kids From Shingles, TooWhooping Cough Vaccine Effectiveness Fades With Time: StudyOpioids Put Alzheimer's Patients at Risk of Pneumonia: StudyHealth Tip: Early Signs of Lyme DiseaseHealth Tip: Hiccup Home RemediesSheep Study Shows a Stuffy Side Effect of VapingShould Air Quality Checks Be Part of Your Travel Planning?Health Tip: Preventing Swimmer's EarHeartburn Drugs Again Tied to Fatal RisksHealth Tip: Nasal Spray SafetyFDA Approves First Drug to Help Tame Cluster HeadachesMany Dietary Supplements Dangerous for TeensAverage American Ingests 70,000 Bits of Microplastic Each YearFalls Are Increasingly Lethal for Older AmericansChicken No Better Than Beef for Your Cholesterol?Another Use for Beta Blockers? Curbing A-fibCaffeine, Nicotine Withdrawal Can Cause Problems in the ICU: StudyYounger Gout Patients Have Higher Odds for Blood ClotsFDA Approves First Test for Zika in Human BloodCDC Warns Again of Salmonella From Pet HedgehogsWhy Some Kids With Eczema Are at Higher Allergy RiskMany Heart Failure Patients Might Safely Reduce Use of DiureticsU.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1992: CDCForget Fasting Before That Cholesterol TestU.S. Cancer Cases, Deaths Continue to Fall'Controlled Burns' Better for Kids' Health Than Wildfires: StudyHighly Processed Diets Tied to Heart Disease, Earlier Death
Questions and AnswersLinks
Related Topics

Diabetes

Window for Safe Use of Clot-Buster Widens for Stroke Patients

HealthDay News
by By Amy NortonHealthDay Reporter
Updated: May 8th 2019

new article illustration

WEDNESDAY, May 8, 2019 (HealthDay News) -- For years, many people suffering a stroke have not been able to get a critical drug due to time limits on its use. Now, a new study suggests that treatment time window can be doubled.

Experts said the findings could open up the treatment option for many more stroke victims.

The drug is called tissue plasminogen activator, or tPA. It can dissolve the blood clot causing a person's stroke, and protect brain tissue from any further damage. However, tPA has to be given within a certain time frame to work.

Long-time guidelines stated that the drug should be infused within three hours of the first stroke symptoms -- or, for certain patients, within 4.5 hours.

That has limited its use. One problem is that people often do not recognize the signs of a stroke and delay going to the hospital, explained Dr. Randolph Marshall, a professor of neurology at Columbia University, in New York City.

He wrote an editorial published with the study.

Another issue is that some people wake up in the midst of a stroke, and it's unclear when the symptoms began.

So, at least as of 2013, only about 6% of patients hospitalized for an ischemic stroke received tPA, according to Marshall.

Ischemic strokes are caused by a clot that blocks blood flow to the brain, and they account for the large majority of all strokes.

In the new trial, researchers looked at whether they could expand the tPA time frame to nine hours in certain ischemic stroke patients. Specifically, that meant cases where brain imaging showed the drug could still be beneficial.

The study took advantage of a newer technology called "perfusion" imaging.

"It allows us to see the area of brain damage, and whether there is still tissue that's salvageable," Marshall explained. It's done using either a CT or MRI scanner.

When patients did have savable brain tissue, the trial found, giving tPA as late as nine hours after the first symptoms still brought benefits. Three months later, over 35% of those patients had no or minimal disability from their stroke.

That compared with 29.5% of patients who were given infusions of a placebo (along with other standard stroke care).

The benefit did come at a price. About 6% of tPA patients had bleeding in the brain -- a known side effect of the drug. But that figure is similar to what's seen when tPA is given earlier, too, Marshall pointed out.

Dr. Geoffrey Donnan, a neurologist at the University of Melbourne, in Australia, led the study.

He said the findings suggest that perfusion imaging should be done whenever a stroke patient either woke up with symptoms, or can be treated within 4.5 to nine hours of their first symptoms.

Perfusion imaging is not universally available, though. Right now, it's mainly used at larger hospitals with comprehensive stroke care, according to Marshall.

The findings are based on 225 stroke patients at hospitals in Australia, Taiwan and New Zealand. All underwent perfusion imaging and were shown to have savable brain tissue. Donnan's team randomly assigned them to have an infusion of either tPA or a placebo fluid.

Many of the patients had woken up with stroke symptoms. Others were known to have suffered their first symptoms within 4.5 to nine hours of being randomly assigned to their treatment.

Still, tPA is not the only stroke treatment option. Doctors can also physically remove the blood clot, using a scope that's threaded into the blocked brain artery. In fact, that procedure -- called a thrombectomy -- can be done as late as 24 hours after the first symptoms in some patients.

It's not known whether giving tPA in the later window would be preferable to a thrombectomy, according to Marshall.

"I think that will be the next big trial -- to compare this with thrombectomy," he said.

For now, Marshall and Donnan both stressed that people should learn the signs and symptoms of stroke, and never delay medical care.

The most common symptoms include sudden weakness or numbness in the face or arm (usually on one side of the body), slurred speech, and sudden difficulty walking or seeing, according to the American Stroke Association.

More information

The American Stroke Association has more on stroke treatment.